Assessment of Operability of Patients With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease - Do We Have the Good Tools to Predict Success? -

被引:52
作者
Myers, Patrick O. [1 ,2 ]
Tissot, Cecile [2 ,3 ]
Beghetti, Maurice [2 ,3 ]
机构
[1] Univ Hosp Geneva, Div Cardiovasc Surg, Geneva, Switzerland
[2] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland
[3] Univ Geneva, Childrens Hosp, Pediat Cardiol Unit, CH-1211 Geneva 14, Switzerland
关键词
Congenital; Heart defects; Pediatrics; Pulmonary hypertension; ATRIAL SEPTAL-DEFECT; ENDOTHELIN-RECEPTOR ANTAGONIST; IMPROVES FUNCTIONAL-CAPACITY; BRAIN NATRIURETIC PEPTIDE; PATENT DUCTUS-ARTERIOSUS; INHALED NITRIC-OXIDE; EISENMENGER-SYNDROME; BOSENTAN THERAPY; DOUBLE-BLIND; MYOCARDIAL-INFARCTION;
D O I
10.1253/circj.CJ-13-1263
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary arterial hypertension (PAH) is a common complication of congenital heart disease, and is now predominantly among patients with uncorrected left-to-right shunts. A growing population is characterized by persistent or recurrent PAH after surgical or interventional correction of left-to-right shunts; the latter having a worse prognosis than other forms of PAH associated with congenital heart disease. New treatments for PAH have been shown to be effective in improving PAH exercise capacity and hemodynamics, raising the hope for making previously inoperable congenital heart defects operable and shifting the framework for the assessment of operability. This review focuses on current methods for assessing operability in PAH associated with congenital heart disease, and the possibility of "treat-and-repair" vs. "repair-and-treat" strategies for patients with inoperable or borderline PAH.
引用
收藏
页码:4 / 11
页数:8
相关论文
共 96 条
  • [1] Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease
    Apostolopoulou, SC
    Manginas, A
    Cokkinos, DV
    Rammos, S
    [J]. HEART, 2005, 91 (11) : 1447 - 1452
  • [2] Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure
    Balint, O. H.
    Samman, A.
    Haberer, K.
    Tobe, L.
    McLaughlin, P.
    Siu, S. C.
    Horlick, E.
    Granton, J.
    Silversides, C. K.
    [J]. HEART, 2008, 94 (09) : 1189 - 1193
  • [3] Inhaled nitric oxide as a preoperative test (INOP Test I) - The INOP Test Study Group
    Balzer, DT
    Kort, HW
    Day, RW
    Corneli, HM
    Kovalchin, JP
    Cannon, BC
    Kaine, SF
    Ivy, DD
    Webber, SA
    Rothman, A
    Ross, RD
    Aggarwal, S
    Takahashi, M
    Waldman, JD
    [J]. CIRCULATION, 2002, 106 (13) : I76 - I81
  • [4] Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan
    Barst, Robyn J.
    Langleben, David
    Badesch, David
    Frost, Adaani
    Lawrence, E. Clinton
    Shapiro, Shelley
    Naeije, Robert
    Galie, Nazzareno
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (10) : 2049 - 2056
  • [5] Can "Inoperable" Congenital Heart Defects Become Operable in Patients with Pulmonary Arterial Hypertension? Dream or Reality?
    Beghetti, Maurice
    Galie, Nazzareno
    Bonnet, Damien
    [J]. CONGENITAL HEART DISEASE, 2012, 7 (01) : 3 - 11
  • [6] PULMONARY ARTERIAL HYPERTENSION AND CONGENITAL HEART DISEASE: TARGETED THERAPIES AND OPERABILITY
    Beghetti, Maurice
    Tissot, Cecile
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (03) : 785 - 786
  • [7] HbA1c in pulmonary arterial hypertension: A marker of prognostic relevance?
    Belly, Michael J.
    Tiede, Henning
    Morty, Rory E.
    Schulz, Richard
    Voswinckel, Robert
    Tanislav, Christian
    Olschewski, Horst
    Ghofrani, Hossein A.
    Seeger, Werner
    Reichenberger, Frank
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (10) : 1109 - 1114
  • [8] Clinical features of paediatric pulmonary hypertension: a registry study
    Berger, Rolf M. F.
    Beghetti, Maurice
    Humpl, Tilman
    Raskob, Gary E.
    Ivy, D. Dunbar
    Jing, Zhi-Cheng
    Bonnet, Damien
    Schulze-Neick, Ingram
    Barst, Robyn J.
    [J]. LANCET, 2012, 379 (9815) : 537 - 546
  • [9] Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: A subgroup analysis
    Berger, Rolf M. F.
    Beghetti, Maurice
    Galie, Nazzareno
    Gatzoulis, Michael A.
    Granton, John
    Lauer, Andrea
    Chiossi, Eleonora
    Landzberg, Michael
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (03) : 373 - 378
  • [10] Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease
    Berner, M
    Beghetti, M
    SpahrSchopfer, I
    Oberhansli, I
    Friedli, B
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (07) : 532 - +